ПодробностиГрафикПрофильМатрица рисковНовостиДокументы

MAGELLAN I/  FR0011238344  /

Fonds
Стоимость чистых активов11.11.2024 Изменение+0.0400 Тип доходности Инвестиционная направленность Инвестиционная компания
21.6600EUR +0.19% reinvestment Equity Emerging Markets Comgest ▶
GlobeNewswire 29.08 Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a ...
GlobeNewswire 28.08 Giant Magellan Telescope Mount Fabrication Begins
GlobeNewswire 20.08 Navios Maritime Partners L.P. Reports Financial Results for the Second Quarter and Six Months Ended ...
GlobeNewswire 08.08 Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
GlobeNewswire 05.08 Diamondback Energy, Inc. Announces Second Quarter 2024 Financial and Operating Results
GlobeNewswire 01.08 Gain Therapeutics to Participate at BTIG Virtual Biotechnology Conference
GlobeNewswire 16.07 Howard Hughes Holdings Inc. Appoints Bhupesh Arora as Chief Technology Officer
GlobeNewswire 09.07 Gain Therapeutics Announces the Completion of Dosing in the Multiple Ascending Dose (MAD) of the Pha...
GlobeNewswire 28.06 Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
GlobeNewswire 28.06 Michael Braham appointed CareSource Military & Veterans president
GlobeNewswire 27.06 Gain Therapeutics, Inc. Appoints Gene Mack as Interim CEO
GlobeNewswire 27.06 Gain Therapeutics Presents GT-02287 Data at Federation of European Neuroscience Societies (FENS) For...
GlobeNewswire 25.06 Gain Therapeutics to Participate at H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference
GlobeNewswire 14.06 Gain Therapeutics Announces Pricing of $11.0 Million Public Offering
GlobeNewswire 13.06 Gain Therapeutics Announces Proposed Public Offering
GlobeNewswire 13.06 Giant Magellan Telescope Enclosure Ready for Construction
GlobeNewswire 30.05 Gain Therapeutics Announces Acceptance of Late-Breaking Abstract for Poster Presentation at Federati...
GlobeNewswire 14.05 Gain Therapeutics Reports Financial Results for First Quarter 2024 and Provides Corporate Update
GlobeNewswire 14.05 Navios Maritime Partners L.P. Reports Financial Results for the First Quarter Ended March 31, 2024
GlobeNewswire 24.04 Gain Therapeutics Announces Positive Results from the Single Ascending Dose (SAD) Part of the Phase ...
GlobeNewswire 08.04 Gain Therapeutics Bolsters Management Team with the Appointment of Gene Mack as Chief Financial Offi...
GlobeNewswire 01.04 Gain Therapeutics Strengthens Management Team and Appoints Jonas Hannestad, M.D., Ph.D. as Chief Med...
GlobeNewswire 27.03 Cegedim Full year 2023 results: Revenue and recurring operating income both up
GlobeNewswire 26.03 Gain Therapeutics Reports Financial Results for Year End 2023 and Provides Corporate Update
GlobeNewswire 15.03 Gain Therapeutics to Present at Public Ventures Discovery Day